ALK-IN-29

• Target:

  ALK|||FAK|||CDK

• Related Pathways:

  Angiogenesis|||Cell Cycle/Checkpoint|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors

• Bioactivity:

  ALK-IN-29 (compound 4c) exhibits inhibitory effects on tyrosine protein kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, displaying a 40.63% inhibition rate at a concentration of 10 ?M. ALK-IN-29 is applicable in cancer research.

• Molecular Formula:

  C29H32FN3O

• Molecular Weight:

  457.58

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C